Niloufer Khan - Concepedia

Author

Niloufer Khan

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

N Khan, N. Khan, Najia Ali Khan, Namira Rasheed Khan, Niloufer Khan

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University University of Chicago Emory University Dana-Farber Cancer Institute

About

Niloufer Khan is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	135
2	Immunology	3	3	99
3	Health Sciences	1	1	35
4	Management	1	1	11
5	Health Policy	1	1	11

Niloufer Khan

Publications

Citations

H-Index

Page 1

	Year	Citations
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes John S. Welch, Allegra A. Petti, Christopher A. Miller, New England Journal of Medicine	2016	774
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation Jonathan U. Peled, Antonio L. C. Gomes, Sean M. Devlin, New England Journal of Medicine	2020	676
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study Niloufer Khan, Sarah Lindner, Antonio L. C. Gomes, Blood	2020	78
Psychological morbidities in adolescent and young adult blood cancer patients during curative‐intent therapy and early survivorship Lori Muffly, Fay J. Hlubocky, Niloufer Khan, Cancer	2016	74
Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma Anita Kumar, Carla Casulo, Ranjana H. Advani, Journal of Clinical Oncology	2021	55
Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors Maha Mamoor, Michael A. Postow, Jessica A. Lavery, Journal for ImmunoTherapy of Cancer	2020	51
The experience of financial toxicity among advanced melanoma patients treated with immunotherapy Bridgette Thom, Maha Mamoor, Jessica A. Lavery, Journal of Psychosocial Oncology	2020	41
Single agents vs combination chemotherapy in relapsed and refractory peripheral T‐cell lymphoma: Results from the comprehensive oncology measures for peripheral T‐cell lymphoma treatment (COMPLETE) registry Robert Stuver, Niloufer Khan, Marc Schwartz, American Journal of Hematology Lymphoid NeoplasiaOncologyEligibility CriteriaComprehensive Oncology MeasuresImmunology	2019	40
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia Niloufer Khan, Andrew Hantel, Randall W. Knoebel, Leukemia & lymphoma/Leukemia and lymphoma	2017	39
ADDITION OF LENALIDOMIDE TO R‐CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG‐ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R‐CHOP Grzegorz S. Nowakowski, Fangxin Hong, David W. Scott, Hematological Oncology Hematological MalignancyLymphoid NeoplasiaAbc DlbclMedicineMalignant Blood Disorder	2019	35

Page 1